Concerto Biosciences Co-Founder and CEO Cheri Ackerman selected as an Ernst & Young Entrepreneur Of The Year® 2023 New England finalist
/PRNewswire/ -- Concerto Biosciences today announced that Co-founder and CEO Cheri Ackerman has been selected by Ernst & Young LLP (EY US) as an Entrepreneur...
Source: prnewswire.com